Immuron CEO Steven Lydeamore to present at Peak Sky High

MELBOURNE, Australia, May 31, 2024 -- Immuron Limited , an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer Steven Lydeamore will...

Related Keywords

Canada ,Australia ,Melbourne ,Victoria ,United States ,American ,Australian ,Flagellin Sears ,Steven Lydeamore ,Immuron Platform Technology ,Immuron Limited ,Securities Exchange ,Nasdaq ,Chief Executive Officer Steven Lydeamore ,Peak Asset Management ,Peak Sky High ,Australian Register ,Therapeutic Goods ,Traveler Diarrhea ,Opin Infect ,Scandinavian Journal ,Tropical Medicine ,Immune Components ,Anti Diarrheagenic Enterotoxigenic Escherichia ,Hyperimmune Bovine Colostrum ,Immuron News ,Securities Act ,Securities Exchange Act ,